Experiences of patients with chronic non-tumor pain undergoing cannabinoid therapy - a qualitative analysis
- Conditions
- F45.41
- Registration Number
- DRKS00034785
- Lead Sponsor
- Klinik für Anästhesiologie Universitätsklinikum Heidelberg - Sektion Schmerzmedizin
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Patients with chronic non-tumor pain, at least two years of continuous cannabinoid therapy or discontinuation of cannabinoid therapy after a maximum of 6 months; therapy costs covered by the respective health insurance company
Exclusion Criteria
Patient refusal to participate in the study, lack of consent, patients not legally capable of giving consent, insufficient understanding of the German language, patients under 18 years of age
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The study aims to explore which psychosocial factors contribute to a response to treatment with cannabinoid medication in patients with chronic non-tumor pain.
- Secondary Outcome Measures
Name Time Method In addition, a contrast should be made between patients with long-term treatment with cannabinoid medication for at least two years and those who discontinue treatment (short-term, maximum six-month treatment).